News

Psyence Biomedical will execute a 1-for-6.25 reverse stock split effective January 20, 2026, reducing outstanding common shares from approximately...

Biomerica secured a national Medicare payment rate of $300 for its InFoods IBS diagnostic, effective January 1, 2026, expanded...

DBV Technologies has secured €166.7 million in gross proceeds after investors fully exercised warrants linked to its March 2025...

Genmab reported topline Phase 3 results from Epcore DLBCL-1 showing that subcutaneous epcoritamab monotherapy improved progression-free survival versus investigator’s...

Zenas BioPharma has granted a non-qualified stock option covering 100,000 shares to a newly hired employee as a Nasdaq...

Liberation Bioindustries has reorganized its founding leadership as it approaches commissioning of a 600,000-liter precision fermentation facility in Richmond,...

DBV Technologies has secured €166.7 million in gross proceeds following the full exercise of warrants tied to its March/April...

Zenas BioPharma has granted a non-qualified stock option to purchase 100,000 shares to a new hire under Nasdaq Listing...

Connect has promoted Cait Kelly to Chief Strategy Officer, adding her to a recently restructured executive team as the...

Foghorn Therapeutics has raised $50 million in a premium-priced equity financing expected to close January 13, 2026, extending its...